Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease.

J Nanoneurosci. 2009 Jun 1;1(1):42-55.

Liu G, Men P, Perry G, Smith MA.

Department of Radiology, University of Utah, Salt Lake City, UT 84108, USA.

Keywords: Alzheimer's disease (AD), blood-brain barrier,  nanoparticle-mediated drug delivery,  chelation agents,  iron-associated neurodegenerative diseases, Friedreich's ataxia, Parkinson's disease, Huntington's disease,  Hallervorden-Spatz Syndrome, nanoparticle technology, very early stages of development.